Lilly Rises
As of 11:05 a.m. ET, Novo Nordisk stock is down a disheartening 20.8%, while both Lilly and Viking stocks are up 4.4% apiece.
After a stunning 703% run-up in price over the past five years, shares of Eli Lilly and Co. have been on a roller-coaster ...
The federal government is phasing out off-brand copies of two blockbuster drugs used to treat obesity and diabetes.
Bloomberg L.P. on MSN1d
Lilly’s US Weight-Loss Drug Shortage Ends, Curtailing CopiesEli Lilly & Co.’s diabetes and weight-loss drugs Mounjaro and Zepbound are no longer in short supply in the US, which means ...
The updates from clinical trials of Eli Lilly's competitors in the obesity market were largely underwhelming this year. See ...
Shares of Danish pharmaceutical giant Novo Nordisk plummeted more than 24% at one point on Friday after reporting trial ...
The FDA declared the tirzepatide shortage over in October 2023, but a lawsuit by Outsourcing Facilities Association, a trade ...
In the spirit of Christmas, Lilly Roofing is giving away a free new roof in hopes of making a difference in someone’s life.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback